Results 21 to 30 of about 1,634 (199)
Objective: Atosiban has demonstrated effectiveness in improving pregnancy outcomes in patients with recurrent implantation failure (RIF). However, the optimal dosage protocol is yet to be established, and only a few studies have directly compared ...
Ming-Ta Chuang +5 more
doaj +2 more sources
Management of preterm labor: atosiban or nifedipine?
Roel de Heus, Eduard J H Mulder, Gerard H A VisserDepartment of Woman and Baby, University Medical Centre Utrecht, The NetherlandsAbstract: Preterm birth is strongly associated with neonatal death and long-term neurological morbidity.
Roel de Heus +2 more
doaj +6 more sources
Atosiban versus placebo in the treatment of threatened preterm birth between 30 and 34 weeks gestation: study protocol of the 4-year APOSTEL 8 follow-up [PDF]
Introduction Currently, the majority of women worldwide with threatened preterm birth are treated with tocolytics. Although tocolytics can effectively delay birth for 48 hours, no tocolytic drug has convincingly been shown to improve neonatal outcomes ...
Martijn A Oudijk +7 more
doaj +2 more sources
Pregnancy and neonatal outcomes of hyperglycemia caused by atosiban administration during pregnancy
It is known that atosiban has fewer side effects than conventional tocolytics. In clinical practice, however, hyperglycemia can be commonly observed in mothers who have been administered atosiban.
Hyun Jin Ko +2 more
doaj +1 more source
On-Resin Synthesis and Late-Stage Functionalization of Macrocyclic Atosiban Mimetics via 5-Iodo-1,4-triazoles. [PDF]
We report an on-resin strategy for synthesizing 5-iodo-1,4-disubstituted-1,2,3-triazole-containing macrocyclic peptides as multifunctional disulfide bridge mimetics.
Shepperson OA +4 more
europepmc +2 more sources
Efficacy of atosiban for repeated embryo implantation failure: A systematic review and meta-analysis
BackgroundRepeated embryo implantation failure (RIF) posed a significant challenge in assisted reproduction. Evidence of its therapeutic effectiveness including atosiban used around embryo transfer to improve pregnancy outcomes in RIF patients undergoing
Ruxin Wang +6 more
doaj +1 more source
Background: Recent developments in assisted reproductive technology focus on potential advances to improve its success rate. Atosiban, a combined oxytocin/vasopressin V1a receptor antagonist, is a novel class of drug involved in basic priming of the ...
Vineet Mishra +5 more
doaj +1 more source
Modern tocolysis and adverse effects of tocolytics [PDF]
Relevance. Toсolytic therapy is the only method that is used in the treatment of pregnant women with preterm labor. However, the effectiveness and safety of this therapy is still a matter of debate.
O R Baev +2 more
doaj +1 more source
Management of preterm labor involves the use of tocolytic drugs to inhibit preterm uterine contractions. This study compared the efficacy and safety of intravenous administration of atosiban and ritodrine in the treatment of spontaneous preterm labor ...
Chia-Hui Lin +4 more
doaj +1 more source
The aim of the study was to compare the efficacy of tocolytic agents - hexoprenaline and atosiban taking into account the gestational age.Patients and methods.
O. R. Baev +3 more
doaj +1 more source

